ES
CEREW

Equitec Specialists’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Equitec Specialists’s Portfolio CEREW Stock Details CEREW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35,825
Closed -$154K – 196
2021
Q1 		$154K Buy
35,825
+15,478
+76% +$70.1K 0.03% 133
2020
Q4 		$115K Buy
+20,347
New +$82.1K 0.01% 134

Other funds holding CEREW

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Equitec Specialists's CEREW Position: Q2 2021 in Review

Equitec Specialists sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q2 2021, closing a stake of 35,825 shares — an estimated $154K sold.

Equitec Specialists first reported a position in CEREW in Q4 2020 and held it in 2 quarters. The position peaked at $154K in Q1 2021. 22 funds tracked by Wall St. Rank hold CEREW as of Q2 2021.

  • Equitec Specialists reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
  • Equitec Specialists sold 35,825 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q2 2021, an estimated $154K.
  • Equitec Specialists first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 2 quarters.
  • Equitec Specialists's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $154K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q2 2021.

Based on Equitec Specialists's 13F filing for Q2 2021, filed 20 Jul 2021.